Vue Weekly interviews biogerontologist Aubrey de Grey: "He proposes that the development of 'rejuvenation therapies' to ward off aging in humans could happen within about 30 to 100 years. 'The only thing that might change that [timescale] is if over the next 10 years from now, the funding is good enough,' de Grey says. This period will be critical, he explains, as he predicts that within this span of time scientists will dramatically improve the longevity of mice. ... 'I think that sort of result [in mice] will be enough to convince society that we can actually do something about aging in humans fairly soon,' he argues, 'and that will change everything.'" Extremely long lived mice will make funding for human radical life extension that much more likely - hence the Methuselah Mouse Prize.